Vascular Medcure logo 103117 (outlines)


is to Design and Develop Advanced Endovascular Devices for Optimal Extraction of Thrombus from the vascular system

60,000-100,000 Americans die of DVT/PE

0 to 30% of people will die within one month of diagnosis

Sudden death is the first symptom in about one-quarter (25%) of people who have a PE

​our device technology

A Novel Thrombectomy System​

Logo Image.png

Vascular Medcure has developed a novel thrombectomy system for the non-surgical removal of soft emboli and thrombi from peripheral blood vessels, PE1, and thrombosed AV Graft1. The CAPERE® Thrombectomy System features a mechanical retrieval method with no need for thrombolytic drugs, aspiration or capital equipment. The system allows complete retrieval of soft emboli and thrombi while providing distal and proximal protection.

PE & AV Graft Device not available for sale

Asset 1_4x.png

​our leaders

​Executive Management Team

Sam 1_edited.jpg

Samuel Shaolian



Duy Nguyen

Co-​Founder & VP

Thanh 1_edited.jpg

Thanh Nguyen

Co-​Founder & VP

​Contact Us

We Want to Hear from You

Thanks for contacting us. We will get back to you as soon as possible.

Tel: 657-549-5175 

Fax: 714-399-0168


1500 South Sunkist Street, Suite H, Anaheim, CA 92806

Vascular Medcure logo 103117 (outlines)

The CAPERE® Thrombectomy System is protected by US Patents No. 9,579116, 9,636,206, 9,744,024, 9,844,386, 9,999,493, 10,070879, 10,143,482, 10,238,482, 10,376,275 and other pending patent applications. CAPERE® is a registered trademark of Vascular Medcure, Inc.